Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0000737 (
abdominal pain
)
31,184
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A factory survey was conducted in a plant where
N,N-dimethylformamide
(
DMF
) was in use during the production of polyurethane plastics and related materials. In all, 318
DMF
-exposed workers (195 men and 123 women) and 143 non-exposed controls (67 men and 76 women) were examined for time-weighted average exposure (to
DMF
and other solvents by diffusive sampling), hematology, serum biochemistry, subjective symptoms, and clinical signs. Most of the exposed workers were exposed only to
DMF
, whereas others were exposed to a combination of
DMF
and toluene.
DMF
exposure in the former group was up to 7.0 ppm (geometric mean on a workshop basis), whereas it was up to 2.1 ppm in combination with 4.2 ppm toluene. Both hematology and serum biochemistry, results (including aspartate and alanine aminotransferases, gamma-glutamyl transpeptidase and amylase) were essentially comparable among the 3 groups. There was, however, a dose-dependent increase in subjective symptoms, especially during work, and in digestive system-related symptoms such as nausea and
abdominal pain
in the past 3-month period. The prevalence rate of alcohol intolerance complaints among male (assumedly) social drinkers was also elevated in relation to
DMF
dose.
...
PMID:Occupational dimethylformamide exposure. 3. Health effects of dimethylformamide after occupational exposure at low concentrations. 157 25
The clinical characteristics, laboratory results, and liver biopsy findings of seven workers with toxic liver injury associated with exposure to several solvents, including substantial levels of the widely used solvent
dimethylformamide
, are presented. Three patients had short exposure (less than 3 months), four long exposure (greater than 1 year). Among those with brief exposure, symptoms included anorexia,
abdominal pain
, and disulfiram-type reaction. Aminotransferases were markedly elevated with the ratio of alanine aminotransferase to aspartate aminotransferase always greater than 1. Liver biopsy showed focal hepatocellular necrosis and microvesicular steatosis with prominence of smooth endoplasmic reticulum, complex lysosomes, and pleomorphic mitochondria with crystalline inclusions. Among workers with long exposure, symptoms were minimal and enzyme elevations modest. Biopsies showed macrovesicular steatosis, pleomorphic mitochondria without crystalloids, and prominent smooth endoplasmic reticulum, but no evidence of persisting acute injury or fibrosis. Abnormal aminotransferases in both groups may persist for months after removal from exposure, but progression to cirrhosis in continually exposed workers was not observed. We conclude that exposure of these workers to solvents, chiefly
dimethylformamide
, may result in two variants of toxic liver injury with subtle clinical, laboratory, and morphological features. This may be readily overlooked if occupational history and biopsy histology are not carefully evaluated.
...
PMID:Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamide. 237 79
Scattered case reports of accidental exposure and a few epidemiological studies have indicated that the liver is the main target organ following acute and chronic exposure to
dimethylformamide
(
DMF
). This has been confirmed in several animal species. In humans, ethanol intolerance is one of the earliest manifestations of (excessive) exposure to
DMF
, followed at higher exposure levels by various complaints (nausea, vomiting,
abdominal pain
) and the release of liver cytolytic enzymes in the plasma. The metabolic pathway of
DMF
has been recently clarified, but the primary cellular lesion responsible for its hepatotoxicity is still unknown.
...
PMID:Dimethylformamide (DMF) hepatotoxicity. 382 92
Dimethylformamide
, an industrial solvent largely used, causes intoxication both by inhalation and cutaneous adsorption. The Authors report the case of a young worker suffering from
abdominal pain
and hepatopathy who was heavily exposed to the solvent. A first diagnosis made by the surgery department was that of acute cholecystitis without gallstones. In the three successive years the worker was controlled and did not show relevant consequences of intoxication.
...
PMID:[An unusual case of "acute abdomen". Dimethylformamide poisoning]. 717 68
Dimethylformamide
(
DMF
), a widely used industrial solvent, has been reported to induce subtle to clinically overt hepatotoxicity. Liver injury due to occupational exposure through inhalation and skin contact have been sporadically reported. We reported a 42-year-old male Taiwanese who developed progressive, intermittent
abdominal pain
for 6 months after working in a synthetic leather factory. Acute hepatitis episode occurred after working in an enclosed and poorly-ventilated workplace for one day. Based on occupational history, pathological examination and serial liver function examinations, the case was compatible with
DMF
-induced acute chemical hepatitis.
...
PMID:Dimethylformamide-induced occupational liver injury--a case report. 981 9